THERAPIST OPPORTUNITIES IN COGNITIVE FUNCTION CORRECTION IN ARTERIAL HYPERTENSION
- Authors: Nedogoda S1, Statsenko M1, Nedogoda S.V.1, Statsenko M.E.1
-
Affiliations:
- Issue: No 10 (2010)
- Pages: 21-27
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/278451
- ID: 278451
Cite item
Full Text
Abstract
The article is dedicated to the problem of cognitive impairments occurring in arterial hypertension. The evidences of relationship between increased blood pressure with high stroke risk and cognitive impairments, as well as effect of antihypertensive therapy on decrease of risk of development of cognitive impairments are presented. The solution algorithm for pharmacotherapeutic goals in these impairments is discussed. Particular attention is paid to the use of neuroprotectors, in particular, Mildronate for correction of cognitive impairments. Mildronate has a pronounced positive effect on cognitive functions in elderly patients with arterial hypertension.
About the authors
S Nedogoda
M Statsenko
Sergey Vladimirovich Nedogoda
Mikhail Evgen'evich Statsenko
References
- Frisoni GB, Galluzzi S, Bresciani L, et al. Mild cognitive impairment with subcortical vascular features. Clinical characteristics and outcome. J Neurol 2002;249:1423-32.
- Lehrl S, Grässel E, Eicke C. Effectiveness of felodipine in hypertensive patients with mild cerebral cognition disorders in a randomized double-blind study. Deutsche medizinische Wochenschrift 2000;125:1350-5.
- Meyer JS, Xu G, Thornby J, et al. Is mild cognitive impairment prodromal for vascular dementia like Alzheimer's disease? Stroke 2002;33:1981-5.
- Murray MD, Lane KA, Gao S, et al. Preservation of cognitive function with antihypertensive medication: a longitudinal analysis of community-based sample of African Americans. Arch Intern Med 2002;162:2090-6.
- Skoog I. A Longitudinal Population Study of the Mini-Mental State Examination in the Very Old: Relation to Dementia and Education. Dementia and Geriatric Cognitive Disorders 2000;11:431-7
- Янсен В, Брукнер Г. Лечение хронической церебральной недостаточности с использованием драже Актовегин форте (двойное слепое плацебо-контролируемое исследование) // РМЖ 2002. Т. 10. С. 543-6.
- Яхно Н.Н., Дамулин И.В., Захаров В.В., Елкин М.Н., Ерохина Л.Г., Стаховская Л.В., Чекнева Н.С., Суслина З.А., Тимербаева С.Л., Федин П.А., Бодарева Э.А., Скоромец А.А., Сорокоумов В.А., Ивашкин В.Т., Гигорьев Ю.В., Первозванский Б.Е. Применение Танакана при начальных стадиях сосудистой мозговой недостаточности: результаты открытого мультицентрового исследования // Неврол. журнал 1998. Т. З. С.18-22.
- Недогода С.В., Цома В.В., Ледяева А.А., Ивашененкова Э.И. Актовегин в коррекции когнитивных нарушений у лиц старческого возраста с артериальной гипертензией // Атмофсфера. Нервные болезни. 2009.№ 1. С. 20-4.
Supplementary files
